Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study

被引：0
|
作者：
Ran Li
Hongge Liang
Jun Li
Zhenyu Shao
Donghong Yang
Jing Bao
Keqiang Wang
Wen Xi
Zhancheng Gao
Renhua Guo
Xinlin Mu
机构：
[1] Peking University People’s Hospital,Department of Respiratory and Critical Care Medicine, Lung Cancer Center
[2] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[3] Qilu Hospital of Shandong University,Department of Radiation Oncology
来源：
BMC Cancer | / 24卷
关键词：
Paclitaxel liposome; Immunotherapy; Immune checkpoint inhibitor; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhang, Kun
    Ma, Xiya
    Gao, Hongjun
    Wang, Hong
    Qin, Haifeng
    Yang, Shaoxing
    Liu, Xiaoqing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3409 - 3417
  • [22] Real-World Outcomes Among Advanced Non-Small Cell Lung Cancer Patients Re-Treated with Immunotherapy in the US
    Spira, A.
    Monnette, A.
    Wentworth, C.
    Doan, J.
    Chang, C.
    Hartman, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S189 - S190
  • [23] Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer
    Khozin, Sean
    Miksad, Rebecca A.
    Adami, Johan
    Boyd, Mariel
    Brown, Nicholas R.
    Gossai, Anala
    Kaganman, Irene
    Kuk, Deborah
    Rockland, Jillian M.
    Pazdur, Richard
    Torres, Aracelis Z.
    Zhi, Jizu
    Abernethy, Amy P.
    CANCER, 2019, 125 (22) : 4019 - 4032
  • [24] Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan
    Morita, Ryo
    Okishio, Kyoichi
    Shimizu, Junichi
    Saito, Haruhiro
    Sakai, Hiroshi
    Kim, Young Hak
    Hataji, Osamu
    Yomota, Makiko
    Nishio, Makoto
    Aoe, Keisuke
    Kanai, Osamu
    Kumagai, Toru
    Kibata, Kayoko
    Tsukamoto, Hiroaki
    Oizumi, Satoshi
    Fujimoto, Daichi
    Tanaka, Hiroshi
    Mizuno, Keiko
    Masuda, Takeshi
    Kozuki, Toshiyuki
    Haku, Takashi
    Suzuki, Hiroyuki
    Okamoto, Isamu
    Hoshiyama, Hirotoshi
    Ueda, Junya
    Ohe, Yuichiro
    LUNG CANCER, 2020, 140 : 8 - 18
  • [25] Real-world retrospective study of KRAS mutations in advanced nonsmall cell lung cancer in the era of immunotherapy
    Bironzo, Paolo
    Cani, Massimiliano
    Jacobs, Francesca
    Napoli, Valerio M.
    Listi, Angela
    Passiglia, Francesco
    Righi, Luisella
    Di Maio, Massimo
    Novello, Silvia
    Scagliotti, Giorgio, V
    CANCER, 2023, 129 (11) : 1662 - 1671
  • [26] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [27] Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data
    Ramos-Guerra, Ana D.
    Farina, Benito
    Perez, Jaime Rubio
    Vilalta-Lacarra, Anna
    Zugazagoitia, Jon
    Peces-Barba, German
    Seijo, Luis M.
    Paz-Ares, Luis
    Gil-Bazo, Ignacio
    Gomez, Manuel Domine
    Ledesma-Carbayo, Maria J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [28] First-line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 insertions: Real-world evidence from China
    Yang, Guangjian
    Yang, Yaning
    Liu, Runze
    Li, Weihua
    Xu, Haiyan
    Hao, Xuezhi
    Li, Junling
    Zhang, Shuyang
    Xu, Fei
    Lei, Siyu
    Wang, Yan
    CANCER MEDICINE, 2023, 12 (01): : 335 - 344
  • [29] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Wang, Fen
    Jin, Feng
    Cheng, Boran
    Zhang, Yue
    Zhou, Qing
    Wang, Shubin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1721 - 1735
  • [30] Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis
    Kobayashi, Keigo
    Nakachi, Ichiro
    Naoki, Katsuhiko
    Satomi, Ryosuke
    Nakamura, Morio
    Inoue, Takashi
    Tateno, Hiroki
    Sakamaki, Fumio
    Sayama, Koichi
    Terashima, Takeshi
    Koh, Hidefumi
    Abe, Takayuki
    Nishino, Makoto
    Arai, Daisuke
    Yasuda, Hiroyuki
    Kawada, Ichiro
    Soejima, Kenzo
    Betsuyaku, Tomoko
    CLINICAL LUNG CANCER, 2018, 19 (03) : E349 - E358
12345